Search Within

Kathryn Cecilia Arbour

Formats
  1. Meeting Abstract (43)
  2. Journal Article (42)
  3. Editorial (2)
  4. Review (2)
Groups
  1. Department of Medicine (89)
  2. Hematology-Oncology Fellows (89)
  3. Solid Tumor Oncology Division (89)
  4. Thoracic Oncology (89)
  5. Weinberg Fellows (89)
  6. GSK Faculty (39)

More Groups

People
  1. Gregory Riely (42)
  2. Matthew Hellmann (40)
  3. Hira Rizvi (32)
  4. Andrew Plodkowski (23)
  5. Charles Rudin (22)
  6. Mark Kris (22)

More People

Years
  1. 2025 (5)
  2. 2024 (10)
  3. 2023 (8)
  4. 2022 (9)
  5. 2021 (11)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (30)
  2. Annals of Oncology (11)
  3. Journal of Thoracic Oncology (11)
  4. Clinical Cancer Research (6)
  5. Cancer Research (4)
  6. Cancer Discovery (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (32)
  2. Elsevier Inc. (16)
  3. American Association for Cancer Research (13)
  4. Oxford University Press (13)
  5. Nature Publishing Group (4)
  6. Massachusetts Medical Society (2)

More Publishers

Results (89)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas
    Journal Article

    Schoenfeld, A. J.; Rizvi, H.; Bandlamudi, C.; Sauter, J. L.; Travis, W. D.; Rekhtman, N.; Plodkowski, A. J.; Perez-Johnston, R.; Sawan, P.; Beras, A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%
    Journal Article

    Gainor, J. F.; Rizvi, H.; Jimenez Aguilar, E.; Skoulidis, F.; Yeap, B. Y.; Naidoo, J.; Khosrowjerdi, S.; Mooradian, M.; Lydon, C.; Illei, P.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Lesion-level response dynamics to programmed cell death protein (PD-1) blockade
    Journal Article

    Osorio, J. C.; Arbour, K. C.; Le, D. T.; Durham, J. N.; Plodkowski, A. J.; Halpenny, D. F.; Ginsberg, M. S.; Sawan, P.; Crompton, J. G.; Yu, H. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • STK11/LKB1 genomic alterations are associated with inferior clinical outcomes with chemo-immunotherapy in non-squamous NSCLC
    Meeting Abstract

    Skoulidis, F.; Arbour, K.; Hellmann, M.; Patil, P.; Marmarelis, M.; Owen, D.; Awad, M.; Murray, J.; Levy, B.; Hellyer, J.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Early change of dNLR is correlated with outcomes in advanced NSCLC patients treated with immunotherapy
    Meeting Abstract

    Mezquita, L.; Preeshagul, I.; Auclin, E.; Saravia, D.; Hendriks, L.; Rizvi, H.; Planchard, D.; Park, W.; Nadal, E.; Ruffinelli, J. C.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Multifactorial model to predict response to PD-(L)1 blockade in patients with high PD-L1 metastatic non-small cell lung cancer
    Meeting Abstract

    Arbour, K.; Oprescu, M.; Hakim, J.; Rizvi, H.; Leiserson, M.; Ginsburg, M.; Plodkowski, A.; Sauter, J.; Preeshagul, I.; Gillett, S.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression
    Journal Article

    Aguilar, E. J.; Ricciuti, B.; Gainor, J. F.; Kehl, K. L.; Kravets, S.; Dahlberg, S.; Nishino, M.; Sholl, L. M.; Adeni, A.; Subegdjo, S.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Validation of broad panel clinical sequencing-based genomic risk stratification in patients with advanced lung adenocarcinomas
    Meeting Abstract

    Whipple, S.; Martin, A.; Martinec, M.; Arbour, K. C.; Seshan, V. E.; Riely, G. J.; Crane, G.; Shen, R.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Association of STK11/LKB1 genomic alterations with lack of benefit from the addition of pembrolizumab to platinum doublet chemotherapy in non-squamous non-small cell lung cancer
    Meeting Abstract

    Skoulidis, F.; Arbour, K. C.; Hellmann, M. D.; Patil, P. D.; Marmarelis, M. E.; Awad, M. M.; Murray, J. C.; Hellyer, J.; Gainor, J. F.; Dimou, A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Molecular correlates of PD-L1 expression in patients with non-small cell lung cancer
    Meeting Abstract

    Rizvi, H.; Bandlamudi, C.; Schoenfeld, A. J.; Sauter, J. L.; Arbour, K. C.; Beras, A.; Egger, J. V.; Ladanyi, M.; Donoghue, M.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save